Compare NextEra Energy, Inc. (NEE) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NextEra Energy, Inc. vs TransMedics Group Inc — how do they compare? NextEra Energy, Inc. trades at $85.5 (market cap $178.85B), while TransMedics Group Inc trades at $87.2 (market cap $3.10B). The key difference: NextEra Energy, Inc. is far larger — about 57.7× TransMedics Group Inc's market cap, and NextEra Energy, Inc. pays a 2.91% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| NEE | TMDX | |
|---|---|---|
Market Cap | $178.85B | $3.10B |
Sector | Utilities | Technology |
52-Week High | $97.88 | $150.42 |
52-Week Low | $69.77 | $61.99 |
Enterprise Value | $286.18B | $3.49B |
Dividend Yield | 2.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NextEra Energy (NEE) trades at $85.45, up 0.89% today, amid a bearish technical signal but strong analyst support. The stock shows robust fundamentals with a 32.4% net income margin and 17.23% ROE, though recent cash flow volatility and rising debt-to-asset ratios (47.6% in 2025) pose concerns. Positive sentiment is driven by AI-driven power demand, highlighted by a $100 billion data center partnership with Brookfield announced on July 29, 2026.
Outlook remains favorable with a consensus price target of $100.40, implying 17.5% upside, supported by 66.66% analyst buy ratings. Key opportunities include AI infrastructure growth and dividend stability, while risks involve high capital expenditures and interest rate sensitivity. Earnings momentum is mixed, with Q1 and Q2 2026 beats offset by a Q4 2025 miss.
TransMedics Group (TMDX) trades at $87.42, down 1.12% on the day, with a bullish technical outlook from moving averages but bearish oscillators signaling potential overbought conditions. The company reported mixed Q2 2026 results, missing earnings estimates with EPS of $0.44 versus $0.50 expected, while revenue growth remains robust. Recent news highlights an ongoing investigation into fiduciary duties by directors, adding uncertainty.
The stock presents a cautious opportunity with strong analyst support (69% buy ratings) and a consensus price target of $99.57, implying upside, but risks include earnings volatility, margin pressures, and legal scrutiny. Fundamentals show solid profitability with a 22.69% net margin, though valuation multiples like P/E of 23.15 suggest premium pricing relative to historical norms.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About NextEra Energy, Inc.
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
